Federica Cattina

812 total citations
35 papers, 282 citations indexed

About

Federica Cattina is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Federica Cattina has authored 35 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 14 papers in Public Health, Environmental and Occupational Health and 11 papers in Genetics. Recurrent topics in Federica Cattina's work include Acute Lymphoblastic Leukemia research (14 papers), Acute Myeloid Leukemia Research (12 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Federica Cattina is often cited by papers focused on Acute Lymphoblastic Leukemia research (14 papers), Acute Myeloid Leukemia Research (12 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Federica Cattina collaborates with scholars based in Italy, United States and Germany. Federica Cattina's co-authors include Domenico Russo, Michele Malagola, Simona Bernardi, Giovanni Martinelli, Ilaria Iacobucci, Valeria Cancelli, Alessandro Turra, Nicola Polverelli, Carla Filì and Cristina Papayannidis and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Federica Cattina

32 papers receiving 280 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Federica Cattina Italy	9	187	136	80	51	44	35	282
Mutlu Kartal‐Kaess Germany	9	161 0.9×	146 1.1×	44 0.6×	56 1.1×	39 0.9×	20	312
Curtis A. Lachowiez United States	10	267 1.4×	168 1.2×	88 1.1×	53 1.0×	27 0.6×	35	319
Ghayas C. Issa United States	8	219 1.2×	118 0.9×	86 1.1×	44 0.9×	49 1.1×	30	291
G. Bug Germany	5	235 1.3×	98 0.7×	87 1.1×	34 0.7×	50 1.1×	7	287
Mahesh Swaminathan United States	8	172 0.9×	111 0.8×	81 1.0×	30 0.6×	26 0.6×	31	239
Giulia Falconi Italy	13	281 1.5×	189 1.4×	124 1.6×	30 0.6×	32 0.7×	28	369
Adil S. A. Al Hinai Netherlands	6	227 1.2×	118 0.9×	90 1.1×	29 0.6×	65 1.5×	7	299
Olatoyosi Odenike United States	9	155 0.8×	134 1.0×	62 0.8×	21 0.4×	22 0.5×	18	235
Jean‐Valère Malfuson France	8	143 0.8×	142 1.0×	42 0.5×	29 0.6×	21 0.5×	15	250

Countries citing papers authored by Federica Cattina

Since Specialization

Citations

This map shows the geographic impact of Federica Cattina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federica Cattina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federica Cattina more than expected).

Fields of papers citing papers by Federica Cattina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federica Cattina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federica Cattina. The network helps show where Federica Cattina may publish in the future.

Co-authorship network of co-authors of Federica Cattina

This figure shows the co-authorship network connecting the top 25 collaborators of Federica Cattina. A scholar is included among the top collaborators of Federica Cattina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federica Cattina. Federica Cattina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cocito, Federica, Luigi Petrucci, Maura Nicolosi, et al.. (2023). Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi. Frontiers in Oncology. 13. 1120967–1120967.

Bernardi, Simona, Mirko Farina, Federica Cattina, et al.. (2020). ETV6: A Candidate Gene for Predisposition to “Blend Pedigrees”? A Case Report from the NEXT-Famly Clinical Trial. SHILAP Revista de lepidopterología. 2020. 1–7. 6 indexed citations

Farina, Mirko, Simona Bernardi, Enrico Morello, et al.. (2020). Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case?. Frontiers in Oncology. 10. 6 indexed citations

Malagola, Michele, Nicola Polverelli, Valeria Cancelli, et al.. (2019). Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner?. SHILAP Revista de lepidopterología. 2019. 1–4. 1 indexed citations

Bernardi, Simona, Chiara Foroni, Federica Re, et al.. (2019). Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia. International Journal of Molecular Medicine. 44(6). 2133–2144. 30 indexed citations

Skert, Cristina, Marco Chiarini, Viviana Giustini, et al.. (2017). Sequential monitoring of lymphocyte subsets and of T-and-B cell neogenesis indexes to identify time-varying immunologic profiles in relation to graft-versus-host disease and relapse after allogeneic stem cell transplantation. PLoS ONE. 12(4). e0175337–e0175337. 9 indexed citations

Cattina, Federica, Simona Bernardi, Vilma Mantovani, et al.. (2017). Single Step Multiple Genotyping by MALDI-TOF Mass Spectrometry, for Evaluation of Minor Histocompatibility Antigens in Patients Submitted to Allogeneic Stem Cell Transplantation from HLA-Matched Related and Unrelated Donor. Hematology Reports. 9(3). 7051–7051. 5 indexed citations

Bernardi, Simona, Michele Malagola, Valeria Cancelli, et al.. (2017). Digital PCR (Dpcr) a Step Forward to Detection and Quantification of Minimal Residual Disease (MRD) in Ph+/BCR-ABL1 Chronic Myeloid Leukemia (CML). Journal of Molecular Biomarkers & Diagnosis. 8(3). 12 indexed citations

Malagola, Michele, Federica Cattina, Valeria Cancelli, et al.. (2017). Favourable/Intermediate ELN-Risk Acute Myeloid Leukemia to Transplant or Not to Transplant First-Line?. Journal of Molecular Biomarkers & Diagnosis. 8(4). 1 indexed citations

10.

Iacobucci, Ilaria, Annalisa Lonetti, Claudia Venturi, et al.. (2014). Use of a high sensitive nanofluidic array for the detection of rare copies of BCR-ABL1 transcript in patients with Philadelphia-positive acute lymphoblastic leukemia in complete response. Leukemia Research. 38(5). 581–585. 18 indexed citations

11.

Skert, Cristina, Manuela Fogli, Emirena Garrafa, et al.. (2014). A specific Toll‐like receptor profile on T lymphocytes and values of monocytes correlate with bacterial, fungal, and cytomegalovirus infections in the early period of allogeneic stem cell transplantation. Transplant Infectious Disease. 16(5). 697–712. 5 indexed citations

12.

Filì, Carla, Michele Malagola, Matilde Y. Follo, et al.. (2013). Prospective Phase II Study on 5-Days Azacitidine for Treatment of Symptomatic and/or Erythropoietin Unresponsive Patients with Low/INT-1–Risk Myelodysplastic Syndromes. Clinical Cancer Research. 19(12). 3297–3308. 56 indexed citations

13.

Russo, Domenico, Michele Malagola, Carla Filì, et al.. (2013). Treatment of Chronic Myeloid Leukemia Elderly Patients in the Tyrosine Kinase Inhibitor Era. Current Cancer Drug Targets. 13(7). 755–767. 7 indexed citations

14.

Iacobucci, Ilaria, Anna Ferrari, Cristina Papayannidis, et al.. (2012). Down-Regulation of BMI-1 Is a New Marker of Sensitivity to Mdm2 Inhibition in B-Acute Lymphoblastic Leukemia.. Blood. 120(21). 2522–2522. 1 indexed citations

15.

Iacobucci, Ilaria, Andrea Ghelli Luserna di Rorà, Maria Vittoria Verga Falzacappa, et al.. (2012). In Vitro and in Vivo Single-Agent Efficacy of Checkpoint Kinase 1 (Chk1) and 2 (Chk2) Inhibitor PF-0477736 (Pfizer) in B- and T-Acute Lymphoblastic Leukemia (ALL). Blood. 120(21). 1496–1496. 3 indexed citations

16.

Skert, Cristina, Manuela Fogli, Emirena Garrafa, et al.. (2012). Profile of Toll-Like Receptors on Peripheral Blood Cells in Relation to Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 19(2). 227–234. 8 indexed citations

17.

Ferrari, Anna, Ilaria Iacobucci, Marco Sazzini, et al.. (2011). Abstract 3811: A germline polymorphism in the ANRIL (CDKN2BAS) locus is associated with susceptibility to Philadelphia-positive acute lymphoblastic leukemia (ALL). Cancer Research. 71(8_Supplement). 3811–3811. 1 indexed citations

18.

Derenzini, Enrico, Ilaria Iacobucci, Elisa Brighenti, et al.. (2011). The Small Molecule CHK1/CHK2 Inhibitor PF-0477736 (Pfizer) Demonstrates Single Agent Activity and Synergizes with Chemotherapy in Diffuse Large B-Cell Lymphoma. Blood. 118(21). 2732–2732. 2 indexed citations

19.

Iacobucci, Ilaria, Federica Cattina, Silvia Pomella, et al.. (2011). The Novel Small Molecule Chk1/Chk2 Inhibitor PF-0477736 (Pfizer) Is Highly Active As Single Agent in Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL). Blood. 118(21). 76–76. 2 indexed citations

20.

Iacobucci, Ilaria, Annalisa Lonetti, Anna Ferrari, et al.. (2010). Use of a High Sensitive Nanofluidic Array for the Detection of Rare Copies of BCR-ABL1 Transcript In Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia (ALL).. Blood. 116(21). 1677–1677. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact